hormonal regulation of metabolism - lecture Flashcards
stimulators of insulin secretion
glucose - on release and synthesis AA, esp. arg FA and ketones GI hormones - glp-1 parasympathetics
inhibitors of insulin secretion
low plasma glucose low plasma AA low plasma FA and ketone levels somatostatin leptin catecholamines (via alpha receptors) sympathetic nervous systems
catecholamines in insulin release
normally inhibit
many more alpha receptors than beta so beta is irrelevant
if patient on drugs that inhibit alpha receptors, catecholamines would stimulate insulin release
inactivation of insulin
has half-life of about 10 minutes
degraded in liver by an insulin specific protease and glutathione-insulin transhydrogenase
glutathione-insulin trashydrogenase
breaks down insulin
c-peptide degradation
half-life 30 minutes
not extracted by liver
degraded and excreted by kidney
proinsulin degradation
half-life of 20 minutes
degraded mainly in kidney
insulin actions in muscle
1: stimulation of glucose uptake into cell (note: exercise and anoxia have comparable action)
2: enhancement of glycogen synthesis
3: stimulation of AA uptake
4: stimulation of protein synthesis
5: inhibition of proteolysis
insulin actions in adipose tissue
1: stimulation of glucose uptake into cell
2: activation of lipoprotein lipase
3: inhibition of hormone sensitive lipase (HSL)
4: enhancement of AA uptake and protein synthesis
insulin actions in liver
1: increases activities of all rate-limiting glycolytic enzymes
2: decreases activity of all rate-limiting gluconeogenic enzymes
3: increases activity of key lipogenic enzymes and FA synthesis
glucagon secretion stimulated by:
low blood glucose AA (esp arginine) free FA and glycerol gut hormones catecholamines neural pathways
glucagon secretion inhibited by
high blood glucose
insulin
somatostatin
rapid actions of glucagon
1: stimulation of glyconeolysis
2: increases cAMP-production and the phos of several protein kinases including the one wihich phos. glycogen synthetase
all actions in liver
delayed actions of glucagons
stimulation of gluconeogenesis
steps in biosynthesis of catecholamines
1: tyrosine hydroxylase converts L-tyrosine to L-dihydroxyphenyl alanine
2: A. acid decarboxylase converts L-dihydroxyphenyl alanine to L-dopamine
3: dopamine beta-oxidase converts l-dopamine to l-norepinephrine
4: phenylethanolamine n-methyltransferase converts norepi to epi (only in adrenal medulla)
inactivation of catecholamines
inactivated very rapidly
can be taken up into storage granules
methylation of phenolic hydroxyl group in position 3 by catechol-O methyl transferase
oxidative deamination by nomamine oxidase
excretion without degradation by kidneys
catechol-O methyl transferase
enzyme that inactivates catecholamines by methylating the phenolic hydroxyl group in position 3
monamine oxidase
enzyme that inactives catecholamines by oxidative deamination
catcholamines in skeletal muscle
1: stimulation of glycogenolysis and lactate production
2: inhibition of glucose uptake and glycogen synthesis
primary effects in muscle (as opposed to glucagon, which has its primary effects in the liver)
catecholamines in adipose tissue
stimulation of lipolysis (via activation of hormone-sensitive lipase)
catecholamines in liver
comparable to those of glucagon
1: stimulation of glycogenolysis
2: inhibition of glucose oxidation and glycogen synthesis
3: stimulation of gluconeogenesis
4: stimulation of lipolysis
anabolic effects of glucocorticoids
1: stimulation of gluconeogenesis and glycogenolysis
2: stimulation of hepatic glycogen synthesis
catabolic effects of glucocorticoids
1: inhibition of glucose uptake in adipose and lymphoid tissue, skin, and muscle
2: inhibition of AA uptake in these tissues
3: inhibition of protein and fat synthesis in these tissues
4: stimulation of lipolysis (activation of hormone-sensitive lipase)
actions of GH in metabolism
1: stimulation of lipolysis (via activation of hormone-sensitive lipase)
2: inhibition of tyrosine-amino transferase in muscle - protects against catabolizing effects of the glucocorticoids and facilitates shunting of AA into hepatic protein synthesis
3: promotes an early increase in glucose uptake in muscle and adipose tissue (insulin-like action) followed by a decrease in glucose uptake
metabolic sequences in untreated type 1 diabetes (for our interest only)
1: insulin lack effects on carbohydrate metabolism result in: decrease in glucose use hyperglycemia glycosurea, osmotic diuresis water and electrolyte loss dehydration hemoconcentration peripheral circulatory failure hypotension low renal and cerebral blood flow anuria eventually coma and death 2: effects on fat metabolism result in: decrease lipogenesis in fat depots mobilization of depot fat lipemia increased ketogenesis in liver ketonemia ketonuria with loss of Na dehydration and hemoconentration peripheral circulatory failure hypotension low renal and cerebral blood flow anuria eventually coma and death 3: effects on protein metabolism result in: increased protein catabolism aminoacidemia increased gluconeogenesis increased urinary nitrogen excretion loss of K etc. from cells net loss of body K cellular dehydration coma and death